Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Whether it is a New Chemical Entity or a mature API, Galenix can help with the characterization and the building up of the Drug Master File (DMF) which is deemed necessary for the final registration process.
The LyoCell technology combines a lipid based approach with nanoparticles. Leveraging the power of reverse cubic phase geometry, the hydrophobic and hydrophilic domains in these nanoparticles are never more than a few nanometers apart giving the particles unique solubilization properties.